Biologics developability data analysis using hierarchical clustering accelerates candidate lead selection, optimization, and preformulation screening
Identification of an optimal single protein sequence at the discovery stage for preclinical and clinical development is critical to the rapid development and overall success of a biologic drug. High throughput developability assessments at the discovery stage are used to rank potent molecules by the...
Saved in:
| Main Authors: | Kevin James Metcalf, Galen Wo, Jan Paulo Zaragoza, Fahimeh Raoufi, Jeanne Baker, Daoyang Chen, Mehabaw Derebe, Jason Hogan, Amy Hsu, Esther Kofman, David Leigh, Mandy Li, Dan Malashock, Cate Mann, Soha Motlagh, Jihea Park, Karthik Sathiyamoorthy, Madhura Shidhore, Yinyan Tang, Kevin Teng, Katharine Williams, Andrew Waight, Sultan Yilmaz, Fan Zhang, Huimin Zhong, Laurence Fayadat-Dilman, Marc Bailly |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2025.2502127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interrogating heterogeneity of cysteine-engineered antibody-drug conjugates and antibody-oligonucleotide conjugates by capillary zone electrophoresis-mass spectrometry
by: Tian Xu, et al.
Published: (2023-12-01) -
Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
by: Tao Wang, et al.
Published: (2025-07-01) -
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies
by: Yuqi Wang, et al.
Published: (2023-12-01) -
VERITAS: Harnessing the power of nomenclature in biologic discovery
by: Riti Biswas, et al.
Published: (2023-12-01) -
Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II
by: Kevin A. Henry, et al.
Published: (2024-12-01)